Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast Cancer

Electroacupuncture treatment of peripheral neuropathy after taxane chemotherapy for breast cancer

Trial Details

NCT ID
NCT06772935
Phase
NA
Sponsor
Affiliated Hospital of Qinghai University
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Electro-acupuncture
Locations (sample)
  • Xining, Qinghai, China|36.62554,101.75739

Key Eligibility Criteria

  • Breast cancer patients diagnosed by pathology;
  • EOOG score is 0 or 1;
  • The age range for enrollment is between 18 and 75 years old; ④ Accept chemotherapy regimens based on taxane drugs (alone or in combination);
  • ⑤ Previously received taxane chemotherapy for more than 6 months;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →